By physician referral or invitation only

A5426 - Improving Physical Ability and Cellular Senescence Elimination in HIV (IPACE-HIV)

To determine if dasatinib and quercetin are safe and if they cause any reactions or side effects when taken together. The study will also see if dasatinib and quercetin can improve physical ability in people with HIV (PWH).

Age & Gender

50 years ~ 99 years
Male, Female

Contact the Team

Location

Thank you for your interest, but this study is recruiting by invitation only.

North Carolina (Alamance, Chatham, Durham, Graham, Guilford, Orange, Wake)

Additional Study Information

Principal Investigator

David Wohl
Institute for Global Health and Infectious Diseases

Study Type

Clinical or Medical
Interventional

Study Topics

Aging
HIV/AIDS

IRB Number

25-1942

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.